The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date)

Abstract Triple-negative breast cancer (TNBC) is characterised by the lack or low expression of estrogen, progesterone, and human epidermal growth factor receptor 2 receptors. TNBC has a high recurrence rate, swiftly metastasizes, and has a high mortality rate. Subsequently, the increase in cases of...

Полное описание

Библиографические подробности

Главные авторы:	Tanaka Ndongwe, Angel-Alberta Zhou, Nelisa Paidamwoyo Ganga, Nyaradzo Matawo, Unami Sibanda, Tinotenda Vanessa Chidziwa, Bwalya A. Witika, Rui W. M. Krause, Gauta Gold Matlou, Xavier Siwe-Noundou
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Springer 2024-09-01
Серии:	Discover Nano
Предметы:	Triple negative breast cancer Nanomaterials Drug delivery systems
Online-ссылка:	https://doi.org/10.1186/s11671-024-04089-3
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!